Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!
Transplantation
.
2021 Aug 1;105(8):e80-e81.
doi: 10.1097/TP.0000000000003856.
Authors
Karsten Midtvedt
1
,
Trung Tran
2
,
Krystina Parker
3
,
Hans-Peter Marti
4
,
Aud-E Stenehjem
5
,
Lasse Gunnar Gøransson
6
7
,
Kari Mørkve Soldal
8
,
Camilla Madsen
9
,
Julia Smedbråten
10
,
Eline Benno Vaage
2
,
Fridtjof Lund-Johansen
2
,
Anders Åsberg
1
11
12
Affiliations
1
Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
2
Department of Immunology, University of Oslo, Oslo, Norway.
3
Department of Nephrology, Akershus University Hospital, Lørenskog, Norway.
4
Department of Medicine, Haukeland University Hospital, Bergen, Norway.
5
Department of Nephrology, Oslo University Hospital, Oslo, Norway.
6
Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway.
7
Department of Clinical Medicine, University of Bergen, Bergen, Norway.
8
Department of Internal Medicine, Innlandet Hospital Trust, Lillehammer, Norway.
9
Nordland Hospital Trust, Department of nephrology, Division of Internal Medicine, Bodø, Norway.
10
Department of Nephrology, Østfold Hospital, Norway.
11
Norwegian Renal Registry, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
12
Department of Pharmacy, University of Oslo, Oslo, Norway.
PMID:
34132229
PMCID:
PMC8294835
DOI:
10.1097/TP.0000000000003856
No abstract available
Publication types
Comment
MeSH terms
BNT162 Vaccine
COVID-19 Vaccines
Immunization
Kidney Transplantation* / adverse effects
Transplant Recipients
Vaccination
Vaccines*
Substances
COVID-19 Vaccines
Vaccines
BNT162 Vaccine